CSL
CSL LIMITED ORDINARYCSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
CSL
CSL
CSL LIMITED ORDINARY
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 1.00% | — |
| 10 July | 1.16% | — |
| 9 July | 1.14% | — |
| 8 July | 1.22% | — |
| 7 July | 1.29% | — |
| 6 July | 1.21% | — |
| 3 July | 1.18% | — |
| 2 July | 1.18% | — |
| 1 July | 1.22% | — |
Csl Limited (CSL) Short Interest Summary
Csl Limited (CSL) currently has 1.00% of its shares sold short (4.8 million shares, worth approximately $585.1 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes CSL the #245 most shorted stock on the ASX most shorted list. Short interest in CSL is down 0.21% over the past week and up 0.19% over the past month. CSL is part of the Health Care sector on the ASX.
Recent CSL Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 1.00% | 4.8M | $121.34 |
| 10 July 2026 | 1.16% | 5.5M | $122.89 |
| 9 July 2026 | 1.14% | 5.4M | $125.53 |
| 8 July 2026 | 1.22% | 5.9M | $124.30 |
| 7 July 2026 | 1.29% | 6.2M | $123.97 |
| 6 July 2026 | 1.21% | 5.8M | $124.23 |
| 3 July 2026 | 1.18% | 5.6M | $121.81 |
| 2 July 2026 | 1.18% | 5.6M | $117.75 |
| 1 July 2026 | 1.22% | 5.8M | $118.37 |
| 30 June 2026 | 1.28% | 6.1M | $114.74 |
CSL Short Selling — Frequently Asked Questions
What is Csl Limited (CSL)'s current short interest?
Csl Limited (CSL) currently has a short interest of 1.00% of total shares outstanding. This means 1.00% of CSL's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is CSL heavily shorted on the ASX?
CSL has a relatively low short interest of 1.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for CSL investors?
Short interest in CSL shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 1.00%, CSL's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this CSL short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for CSL.